» Articles » PMID: 16735043

Molecular Mechanisms Mediating Gastrin-releasing Peptide Receptor Modulation of Memory Consolidation in the Hippocampus

Overview
Specialties Neurology
Pharmacology
Date 2006 Jun 1
PMID 16735043
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Although the gastrin-releasing peptide-preferring bombesin receptor (GRPR) has been implicated in memory formation, the underlying molecular events are poorly understood. In the present study, we examined interactions between the GRPR and cellular signaling pathways in influencing memory consolidation in the hippocampus. Male Wistar rats received bilateral infusions of bombesin (BB) into the dorsal hippocampus immediately after inhibitory avoidance (IA) training. Intermediate doses of BB enhanced, whereas a higher dose impaired, 24-h IA memory retention. The BB-induced memory enhancement was prevented by pretraining infusions of a GRPR antagonist or inhibitors of protein kinase C (PKC), mitogen-activated protein kinase (MAPK) kinase and protein kinase A (PKA), but not by a neuromedin B receptor (NMBR) antagonist. We next further investigated the interactions between the GRPR and the PKA pathway. BB-induced enhancement of consolidation was potentiated by coinfusion of activators of the dopamine D1/D5 receptor (D1R)/cAMP/PKA pathway and prevented by a PKA inhibitor. We conclude that memory modulation by hippocampal GRPRs is mediated by the PKC, MAPK, and PKA pathways. Furthermore, pretraining infusion of BB prevented beta-amyloid peptide (25-35)-induced memory impairment, supporting the view that the GRPR is a target for the development of cognitive enhancers for dementia.

Citing Articles

IL-6 Enhances the Activation of PI3K-AKT/mTOR-GSK-3β by Upregulating GRPR in Hippocampal Neurons of Autistic Mice.

Li H, Wang X, Hu C, Cui J, Li H, Luo X J Neuroimmune Pharmacol. 2024; 19(1):12.

PMID: 38536552 PMC: 10972920. DOI: 10.1007/s11481-024-10111-3.


Advances of radiolabeled GRPR ligands for PET/CT imaging of cancers.

Yuze Ma , Gao F Cancer Imaging. 2024; 24(1):19.

PMID: 38279185 PMC: 10811881. DOI: 10.1186/s40644-024-00658-y.


Bombesins: A New Frontier in Hybrid Compound Development.

Serafin P, Kleczkowska P Pharmaceutics. 2023; 15(11).

PMID: 38004575 PMC: 10674911. DOI: 10.3390/pharmaceutics15112597.


Serum Metabolites Differentiate Amnestic Mild Cognitive Impairment From Healthy Controls and Predict Early Alzheimer's Disease via Untargeted Lipidomics Analysis.

Zhang L, Li L, Meng F, Yu J, He F, Lin Y Front Neurol. 2021; 12:704582.

PMID: 34408722 PMC: 8365883. DOI: 10.3389/fneur.2021.704582.


Lithium alters expression of RNAs in a type-specific manner in differentiated human neuroblastoma neuronal cultures, including specific genes involved in Alzheimer's disease.

Maloney B, Balaraman Y, Liu Y, Chopra N, Edenberg H, Kelsoe J Sci Rep. 2019; 9(1):18261.

PMID: 31797941 PMC: 6892907. DOI: 10.1038/s41598-019-54076-3.